The Global Lung Cancer Therapeutics Market was worth $5.65 billion in 2016 and estimated to be growing at a CAGR of 6.7%, to reach $7.81 billion by 2021. Lung cancer is the second most commonly detected and has the highest death rate of all cancers in both men and women. Cigarette smoking is the projecting cause of lung cancer.
The Global Lung Cancer Therapeutics Market was worth $5.65 billion in 2016 and estimated to be growing at a CAGR of 6.7%, to reach $7.81 billion by 2021. Lung cancer is the second most commonly detected and has the highest death rate of all cancers in both men and women. Cigarette smoking is the projecting cause of lung cancer.
